Roivant Sciences Ltd. (NASDAQ:ROIV) Receives Consensus Ratin

Shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) have been given an average rating of “Moderate Buy” by the ten research firms that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. […]

Related Keywords

, Principal Financial Group Inc , Roivant Sciences , Analyst Recommendations For Roivant Sciences , Deutsche Bank Aktiengesellschaft , Roivant Sciences Ltd , Allspring Global Investments Holdings , Roivant Sciences Price Performance , Goldman Sachs Group , Institutional Trading Of Roivant Sciences , News Ratings For Roivant Sciences Daily , Nasdaq , York Mellon Corp , Get Free Report , Marketbeat Ratings , Bank Aktiengesellschaft , New York Mellon Corp , Global Investments Holdings , Financial Group , Atalaya Capital Management , Get Free , Sciences Ltd , Roivant Sciences Daily ,